Chemotherapeutic drugs and mitochondrial dysfunction: focus on doxorubicin, trastuzumab, and sunitinib

S Gorini, A De Angelis, L Berrino… - Oxidative medicine …, 2018 - Wiley Online Library
Many cancer therapies produce toxic side effects whose molecular mechanisms await full
elucidation. The most feared and studied side effect of chemotherapeutic drugs is …

Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress

LAA Gilliam, DK St. Clair - Antioxidants & redox signaling, 2011 - liebertpub.com
Significance: Fatigue is one of the most common symptoms of cancer and its treatment,
manifested in the clinic through weakness and exercise intolerance. These side effects not …

Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs

C Oleaga, C Bernabini, AST Smith, B Srinivasan… - Scientific reports, 2016 - nature.com
We report on a functional human model to evaluate multi-organ toxicity in a 4-organ system
under continuous flow conditions in a serum-free defined medium utilizing a pumpless …

Exercise training during chemotherapy preserves skeletal muscle fiber area, capillarization, and mitochondrial content in patients with breast cancer

S Mijwel, DA Cardinale, J Norrbom… - The FASEB …, 2018 - Wiley Online Library
Exercise has been suggested to ameliorate the detrimental effects of chemotherapy on
skeletal muscle. The aim of this study was to compare the effects of different exercise …

Proteasomal degradation of TRAF2 mediates mitochondrial dysfunction in doxorubicin-cardiomyopathy

R Dhingra, I Rabinovich-Nikitin, S Rothman… - Circulation, 2022 - Am Heart Assoc
Background: Cytokines such as tumor necrosis factor-α (TNFα) have been implicated in
cardiac dysfunction and toxicity associated with doxorubicin (DOX). Although TNFα can elicit …

Doxorubicin‐induced skeletal muscle atrophy: elucidating the underlying molecular pathways

AE Hiensch, KA Bolam, S Mijwel… - Acta …, 2020 - Wiley Online Library
Aim Loss of skeletal muscle mass is a common clinical finding in cancer patients. The
purpose of this meta‐analysis and systematic review was to quantify the effect of doxorubicin …

Skeletal muscle atrophy and dysfunction in breast cancer patients: role for chemotherapy-derived oxidant stress

BA Guigni, DM Callahan, TW Tourville… - … of Physiology-Cell …, 2018 - journals.physiology.org
How breast cancer and its treatments affect skeletal muscle is not well defined. To address
this question, we assessed skeletal muscle structure and protein expression in 13 women …

Tumor-associated macrophages induce inflammation and drug resistance in a mechanically tunable engineered model of osteosarcoma

LK Chim, IL Williams, CJ Bashor, AG Mikos - Biomaterials, 2023 - Elsevier
The tumor microenvironment is a complex and dynamic ecosystem composed of various
physical cues and biochemical signals that facilitate cancer progression, and tumor …

Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin‐induced cardiac and skeletal muscle myopathy

K Min, OS Kwon, AJ Smuder, MP Wiggs… - The Journal of …, 2015 - Wiley Online Library
Key points Although doxorubicin is a highly effective anti‐tumour agent, the administration of
this drug is associated with significant side effects, including contractile dysfunction and …

Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes

LAA Gilliam, JS Moylan, EW Patterson… - … of Physiology-Cell …, 2012 - journals.physiology.org
Doxorubicin, a commonly prescribed chemotherapeutic agent, causes skeletal muscle
wasting in cancer patients undergoing treatment and increases mitochondrial reactive …